New Study Identifies Two Genes That Combine to Cause Rare Syndrome
Researchers find genetic mutations which appear to underlie a rare syndrome which combines reproductive failure with cerebella ataxi and dementia.
New Research on the Effects of Traumatic Brain Injury
According to three new studies, numerous opportunities exist to improve the outcomes of TBI in older adults.
Dynamic New Software Improves Care of Aging Brain
Researchers develop new medical records software which helps monitor the health of the aging brain.
Buphenyl Identified as a Possible Drug for Alzheimer’s Disease
Buphenyl (sodium phenylbutyrate), a medication approved for the treatment of hyperammonemia, could help prevent the progression of Alzheimer’s disease, a new study finds.
Age Related Dementia May Begin with Neurons’ Inability to Rid Themselves of Unwanted Proteins
Researcher discover age related dementia likely occurs due to the declining ability for neurons to dispose of unwanted aggregated proteins.
Misplaced Molecules: New Insights into the Causes of Dementia
New research supports the idea that a malfunction of the TDP-43 protein plays a decisive role in the development of ALS and FTD.
Researchers Identify Possible Treatment Window for Memory Problems
A new study identifies a potential treatment window of several years for plaques in the brain considered to cause memory loss in diseases such as Alzheimer’s.
Researchers Find Controlling Element of Huntington’s Disease
Researchers discover a three molecule complex could be a target for treating Huntington’s Disease, a genetic and currently incurable brain disease which causes movement disorders and dementia.
Genome-Wide Imaging Study Identifies New Gene Associated with Alzheimer’s Plaques
Researchers combined genetic data with neuroimaging in order to identify genes associated with amyloid plaque deposits in Alzheimer’s disease patients. The study is believed to be the first genome-wide association study of plaque deposits using a specialized PET scan tracer that binds to amyloid.
It’s Not Just Amyloid: White Matter Hyperintensities and Alzheimer’s Disease
A new study suggest that along with amyloid deposits, white matter hyperintensities may be a second necessary factor for the development of Alzheimer’s disease.
